Shanghai Sanmao Enterprise: Last year, the net profit after deducting non-recurring items increased by over 50% year-on-year, and import and export trade showed a slight profit | Interpretations

①Shanghai Sanmao Enterprise's revenue for the year 2024 is 1.203 billion yuan, achieving growth for three consecutive years. However, the net income attributable is only 18.4503 million yuan. ②The company stated on the investor interaction platform that direct exports of goods to the United States account for about one-fifth of the company's total annual export volume.

cls.cn19:07 ET

Brokerage morning meeting highlights: Countermeasures against tariffs boost Shenzhen Agricultural Products Group prices, the planting chain directly benefits.

At today's Brokerage morning meeting, CITIC SEC believes that countermeasures against tariffs boost the prices of Shenzhen Agricultural Products Group, which directly benefits the planting chain; HAITONG SEC proposed a bullish view on the relative yields of the Banks Sector in April; Galaxy Securities stated that it focuses on Gold and countermeasures against rare earths.

cls.cnApr 7 20:33 ET

Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.

In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.

cls.cnApr 6 20:17 ET

Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 2 21:09 ET

NanJing Public Utilities Development frequently takes action to transform, will the battery-swapping Technology company Yugu reach the public market through a curve? | Quick reading of the announcement.

① NanJing Public Utilities Development plans to acquire YuGu Technology, whose main Business provides battery swapping services for delivery riders, having halted its IPO process six months ago; ② In recent years, while YuGu Technology's revenue has grown, its gross margin has continued to decline, and NanJing Public Utilities Development has fallen into a loss trap; ③ NanJing Public Utilities Development is frequently acquiring external Assets to accelerate its transformation towards New energy Fund, and recently acquired NanJing Energy Network.

cls.cnJan 10 10:44 ET

Repurchase amount does not meet the standard, jilin yatai group is ordered to make corrections | Speed reading announcement

①Upon the expiration of the repurchase period, jilin yatai repurchased amount is below the lower limit of the total repurchase amount, jilin Securities Regulatory Bureau requested correction. ②Jilin Securities Regulatory Bureau decided to take regulatory measures to order the company to make corrections, and record it in the integrity files of the securities and futures market.

cls.cnNov 8, 2024 10:46 ET